1,5-anhydroglucitol has been researched along with eicosapentaenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Amaya, N; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Tada, H; Uzui, H | 1 |
2 other study(ies) available for 1,5-anhydroglucitol and eicosapentaenoic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease.
Topics: AC133 Antigen; Aged; Antigens, CD34; Cell Count; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Eicosapentaenoic Acid; Endothelium, Vascular; Female; Humans; Hyperglycemia; Male; Middle Aged; Neovascularization, Pathologic; Risk Factors; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2016 |